Consultant watch: Opioid enabler McKinsey gets to write the script on scripts

By Bernard Keane

July 7, 2023

McKinsey
Among the millions raked in by consultants in June, McKinsey stands out for using its experience in the US opioid epidemic in Australia. (Casimiro/Adobe)

Who’s winning the battle to mop up the taxpayer gravy left by PwC’s ignominious exit from consulting in Canberra?

In the first of a monthly series, we’ll be looking at what AusTender tells us about consulting contracts being let by commonwealth agencies to determine who’s enjoying taxpayer largesse for PowerPoint presentations, economic modelling, risk management analyses and consultation management strategies.

As the end of the financial year loomed, Deloitte was the overall winner in June, with $2.6 million in consulting contracts and another $1.5

Subscribe for unlimited access

A Mandarin Premium subscription gives you access to all articles, webinars, discounted early-bird event invites and more.

INTRO OFFER - 40% OFF

ANNUAL $440$264

Save 40% on premium access for new accounts.
Just $22/month for your first year.
Renews at $440/year until cancelled.

MONTHLY $44

Unlimited access for just $10 per week. Cancel anytime.

About the author

Any feedback or news tips? Here’s where to contact the relevant team.

The Mandarin Premium

Try Mandarin Premium for $4 a week.

Access all the in-depth briefings. New subscribers only.

Get Premium Today